US group Danaher has completed its takeover of Abcam, a UK firm specialising in antibodies and life science consumables, for $5.7 billion (£4.5 billion) in cash. Abcam is now a wholly owned subsidiary of Danaher. The sale had faced opposition from Abcam founder Jonathan Milner, who accused the Abcam board of poor performance during the summer. […]
Read More